AI
AdvisorShares Investments Portfolio holdings
AUM
$555M
1-Year Return
19.49%
This Quarter Return
+0.86%
1 Year Return
+19.49%
3 Year Return
+67.68%
5 Year Return
+78.74%
10 Year Return
–
AUM
$574M
AUM Growth
-$19M
(-3.2%)
Cap. Flow
+$14.7M
Cap. Flow
% of AUM
2.56%
Top 10 Holdings %
Top 10 Hldgs %
54.1%
Holding
346
New
71
Increased
77
Reduced
103
Closed
73
Top Buys
| 1 |
iShares Morningstar Growth ETF
ILCG
|
$40.6M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
$1.48M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
$1.4M |
| 4 |
Intuit
INTU
|
$935K |
| 5 |
Thermo Fisher Scientific
TMO
|
$844K |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$39.8M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
$1.93M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$1.44M |
| 4 |
Energy Select Sector SPDR Fund
XLE
|
$1.09M |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$838K |
Sector Composition
| 1 | Technology | 9.43% |
| 2 | Healthcare | 8.14% |
| 3 | Financials | 7.38% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Industrials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
GH Research
GHRS
$874M
| $266K | 0.05% |
22,605
-7,458
| -25% | -$87.6K |
|
|
TBCH
202
Turtle Beach Corporation Common Stock
TBCH
$305M
| $262K | 0.05% |
18,477
-756
| -4% | -$10.7K |
|
203
Molson Coors Class B
TAP
$9.96B
| $258K | 0.04% |
5,094
-208
| -4% | -$10.5K |
|
204
MGP Ingredients
MGPI
$622M
| $253K | 0.04% |
3,465
-142
| -4% | -$10.4K |
|
|
ITCI
205
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $252K | 0.04% |
3,705
-870
| -19% | -$59.2K |
|
|
NAPA
206
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $251K | 0.04% |
35,792
+16,536
| +86% | +$116K |
|
207
Incannex Healthcare
IXHL
$49.2M
| $238K | 0.04% |
80,002
+29,087
| +57% | +$86.4K |
|
208
Brinker International
EAT
$7.04B
| $227K | 0.04% |
3,131
| – | – |
|
209
WM Technology
MAPS
$126M
| $224K | 0.04% |
+200,000
| New | +$224K |
|
210
CAVA Group
CAVA
$7.73B
| $224K | 0.04% |
2,350
| – | – |
|
|
INCR
211
Intercure
INCR
$86.1M
| $218K | 0.04% |
+107,414
| New | +$218K |
|
212
Clearmind Medicine
CMND
$5.54M
| $214K | 0.04% |
128,641
+15,948
| +14% | +$26.5K |
|
213
Skye Bioscience
SKYE
$124M
| $210K | 0.04% |
+26,000
| New | +$210K |
|
214
Target Hospitality
TH
$876M
| $192K | 0.03% |
22,589
+5,624
| +33% | +$47.7K |
|
|
DRUG
215
Bright Minds Biosciences
DRUG
$299M
| $190K | 0.03% |
180,992
+4,954
| +3% | +$5.2K |
|
216
Enveric Biosciences
ENVB
$2.95M
| $190K | 0.03% |
21,136
+5,214
| +33% | +$46.8K |
|
217
Expedia Group
EXPE
$26.6B
| $186K | 0.03% |
1,517
+100
| +7% | +$12.3K |
|
218
Trip.com Group
TCOM
$47.6B
| $185K | 0.03% |
3,896
-868
| -18% | -$41.3K |
|
219
VistaGen Therapeutics
VTGN
$109M
| $185K | 0.03% |
51,780
-20,291
| -28% | -$72.4K |
|
|
SAGE
220
DELISTED
Sage Therapeutics
SAGE
| $177K | 0.03% |
16,030
+1,918
| +14% | +$21.2K |
|
221
Dutch Bros
BROS
$8.38B
| $176K | 0.03% |
4,210
| – | – |
|
222
Royal Caribbean
RCL
$95.7B
| $172K | 0.03% |
1,100
-532
| -33% | -$83.2K |
|
223
InterContinental Hotels
IHG
$18.8B
| $164K | 0.03% |
1,583
+668
| +73% | +$69.3K |
|
|
XHR
224
Xenia Hotels & Resorts
XHR
$1.38B
| $164K | 0.03% |
+11,780
| New | +$164K |
|
225
Chipotle Mexican Grill
CMG
$55.1B
| $164K | 0.03% |
2,650
| – | – |
|